- Home
- CHRS vs SMHI Comparison
CHRS vs SMHI Comparison
Compare CHRS & SMHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- SMHI
- Stock Information
- Founded
- CHRS 2010
- SMHI 1989
- Country
- CHRS United States
- SMHI United States
- Employees
- CHRS N/A
- SMHI N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- SMHI Marine Transportation
- Sector
- CHRS Health Care
- SMHI Consumer Discretionary
- Exchange
- CHRS Nasdaq
- SMHI Nasdaq
- Market Cap
- CHRS 84.2M
- SMHI 139.9M
- IPO Year
- CHRS 2014
- SMHI N/A
- Fundamental
- Price
- CHRS $0.82
- SMHI $5.68
- Analyst Decision
- CHRS Buy
- SMHI
- Analyst Count
- CHRS 3
- SMHI 0
- Target Price
- CHRS $4.68
- SMHI N/A
- AVG Volume (30 Days)
- CHRS 1.3M
- SMHI 122.9K
- Earning Date
- CHRS 08-07-2025
- SMHI 07-30-2025
- Dividend Yield
- CHRS N/A
- SMHI N/A
- EPS Growth
- CHRS N/A
- SMHI N/A
- EPS
- CHRS N/A
- SMHI N/A
- Revenue
- CHRS $272,251,000.00
- SMHI $264,089,999.00
- Revenue This Year
- CHRS N/A
- SMHI N/A
- Revenue Next Year
- CHRS $106.56
- SMHI $11.59
- P/E Ratio
- CHRS $1.87
- SMHI N/A
- Revenue Growth
- CHRS 19.87
- SMHI N/A
- 52 Week Low
- CHRS $0.66
- SMHI $3.63
- 52 Week High
- CHRS $2.43
- SMHI $15.36
- Technical
- Relative Strength Index (RSI)
- CHRS 53.13
- SMHI 49.61
- Support Level
- CHRS $0.72
- SMHI $4.94
- Resistance Level
- CHRS $0.77
- SMHI $5.42
- Average True Range (ATR)
- CHRS 0.04
- SMHI 0.30
- MACD
- CHRS 0.01
- SMHI -0.06
- Stochastic Oscillator
- CHRS 91.62
- SMHI 33.15
About CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.
About SMHI SEACOR Marine Holdings Inc.
Seacor Marine Holdings Inc provides marine and support transportation services to offshore energy facilities globally. The company operates and manages a diverse fleet of offshore support vessels that deliver cargo and personnel to offshore installations, including wind farms, handle anchors, and mooring equipment for offshore rigs and platforms. Its geographical segment includes the United States (Gulf of Mexico), Africa and Europe, Middle East and Asia, and Latin America.